Secondary Analyses


Below is a summary of completed, in progress, and planned secondary analyses for the VICTORIA study.

AnalysesStatus
(Completed, In Progress, Planned)
Related Links
Contextual with other trialsCompletedCirculation publication
Impact of natriuretic peptides on
result and their evolution
CompletedJACC FF publication
HFA 20 presentation
Index admission groupsCompletedJAMA Cardiol. publication
Anemia CompletedCirculation publication
Baseline changes in renal functionCompletedEur J Heart Fail. publication
Sequential natriuretic peptides
and outcomes
CompletedJACC HF publication
HFA 21 presentation
Atrial fibrillation CompletedEur J Heart Fail publication
HFA 21 presentation
Safety/hypotension/syncope/
BP response
CompletedJAHA publication
HFA 21 presentation
CAD/non CADCompletedEur J Heart Fail publication
ACC 21 presentation
Sacubitril/valsartan baseline/
drop ins
CompletedEur J Heart Fail publication
ECHO 1 paired data & Rx effectCompletedEur J Heart Fail publication
HFA 20 presentation
BiomarkersCompletedJ Card Fail publication
ACC 21 presentation
Health economicsCompletedCirculation publication
NA registryCompletedCirc Heart Fail publication
HFSA 20 presentation
NA Registry – GDMTCompletedJ Card Fail publication
HFSA 20 presentation
PK/PD & PK adherenceCompletedClin Pharmacol Ther publication
QoL as an outcome/predictorCompletedCirc Heart Fail publication
Sex/AgeCompletedJACC Heart Fail publication
Screening NT-proBNPCompletedCirc Heart Fail publication
ECG parametersCompletedEur J Heart Fail publication
Standard of careCompletedCirc Heart Fail publication
HFSA 2020 presentation
Prognostic modelCompletedJ Card Fail publication
HFA 21 presentation
LVEF stratificationCompletedJACC Heart Fail publication
Diabetes In Progress
Recurrent eventsIn Progress
Geographic variationIn Progress
Expanded endpointsIn Progress
ECHO 2: remodelingIn Progress